Le Lézard
Classified in: Health
Subject: SVY

World Point of Care Diagnostics Market Size and Market Share Analysis Report 2017

DUBLIN, October 5, 2017 /PRNewswire/ --

The "World Point of Care Diagnostics Market Size and Market Share Analysis" report has been added to Research and Markets' offering.

Research and Markets Logo

This research estimates the point of care diagnostics testing market at $18.4 billion, according to our latest market research study conducted this year.

This report, World Point of Care Diagnostics Market Size and Market Share Analysis, features in-depth analysis of the market for the traditional set of point of care diagnostics tests: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, hemoglobin diagnostics, infectious disease testing and cholesterol screening. In the past 5-10 years the following tests were added: HgA1c, B-Type Natriuretic Peptide (BNP), whole-blood lactate, D-Dimer, C-Reactive Protein (CRP).

Emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are transforming the point of care diagnostic market. The driving force behind these innovations in healthcare is to provide expedited diagnosis where the patient is seen or in the patient's home. The POC diagnostics industry will be part of a paradigm shift from curative medicine to predictive, personalized and preemptive medicine. Globally, millions of dollars are spent annually on point of care diagnostic testing, both professional testing and self-testing.

What's the size of the market opportunity in each rapid and near-patient diagnostic testing segment? Who's winning in point of care diagnostics market share? This updated superior resource, World Point of Care Diagnostics Market Size and Market Share Analysis, focuses on the global market for point of care diagnostics.

Roche, Alere, Abbott, and Siemens are among the largest companies in point of care (POC) diagnostics in terms of revenues. Together these companies make up three-fourths of the entire point of care diagnostics market. Point of care systems are designed to deliver test results in a location and timing to be useful during a patient visit. They consist of devices such as glucose meters operated by a patient or small analyzers operated in a physician office lab.

Roche dominated the point of care diagnostics market as it does in several other in IVD (in vitro diagnostics) categories. Coagulation and glucose testing are key areas. In June 2015, Roche introduced the cobas c 513 blood glucose analyzer. It is a dedicated, high-throughput HbA1c analyzer suitable for diagnosis, monitoring and risk identification of diabetes patients.

Waltham, MA-based Alere secured the second market position Alere participates in nearly all POC test segments but has a dominating position in rapid cardiac markers.

In-Depth Point of Care Diagnostics Market Information, including:

Issues & Trends Affecting the Point of Care Diagnostics Testing Market include:

Key Topics Covered:
1: Executive Summary

2: Introduction And Overview

3: PoC Blood Glucose Tests

4: PoC Blood And Electrolytes Testing Market

5: PoC Rapid Coagulation

6: PoC Rapid Cardiac Markers

7: PoC Drug Testing

8: PoC Pregnancy And Fertility Testing

9: PoC Colon Cancer Screening/Fecal Occult Blood Testing

10: PoC Infectious Disease Testing

11: PoC Cholesterol Testing

12: PoC Cancer Tumor Marker Testing

13: PoC Urine Strip Testing

14: Miscellaneous PoC Testing

15: Issues And Trends In Point Of Care

16: Overall Global PoC Testing Market And Market Share Analysis

17: Corporate Profiles

For more information about this report visit https://www.researchandmarkets.com/research/3d78ll/world_point_of

Media Contact:

Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


SOURCE Research and Markets

These press releases may also interest you

at 12:00
ATLANTA, Oct. 20, 2017 /PRNewswire/ -- On Saturday, October 14th the multi-platinum GRAMMY award-winning Zac Brown Band took the stage at the Southern Ground Amphitheater in Fayetteville, Georgia for the sixth annual Night of Candles benefit show in...

at 11:56
TORONTO, Oct. 20, 2017 /CNW/ - Today, the National Coalition Against Contraband Tobacco (NCACT) highlighted the hypocrisy evident in Ontario's Cannabis Legalization Enforcement Summit in terms of the emphasis being placed on enforcement measures to...

at 11:48
NEW YORK, Oct. 20, 2017 /PRNewswire/ -- Daily stress and environmental aggressors can leave you with a complexion congested with debris, toxins, and excess oil. Whether you're running errands in the city or the suburbs, environmental toxins affect us...

at 11:46
WASHINGTON, Oct. 20, 2017 /PRNewswire-USNewswire/ -- Commenting on health insurer Anthem's announcement that it will launch its own "in house" pharmacy benefit manager (PBM) to be managed by CVS Health Corp., the Senior Care Pharmacy Coalition (SCPC)...

at 11:42
WEST SPRINGFIELD, Mass., Oct. 20, 2017 /PRNewswire-USNewswire/ -- The Massachusetts Nurses Association, the state's largest union and professional association for registered nurses and health care professionals, announces its endorsement of Lida...

at 11:30
DUBLIN, October 20, 2017 /PRNewswire/ -- The "The Future of the U.S. Biologics and Biosimilars Treatment Market for Psoriasis" report has been added to Research and Markets' offering. Focus Areas Psoriasis disease deep dive, in-depth...

News published on 5 october 2017 at 11:30 and distributed by: